Click Therapeutics
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Domain
clicktherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$48.6M
Founded
2012
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Click Therapeutics use?+
Click Therapeutics uses 11 technologies including GSAP, Next.js, Plausible.
What industry is Click Therapeutics in?+
Click Therapeutics operates in the Biotechnology industry.
Where is Click Therapeutics based?+
Click Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026